Poverty, Genetics and the White American Psyche
By Tanya H. Lee,
Indian Country
| 02. 05. 2015
The sequencing of the human genome and the science that made that feat possible have led to some fascinating new research into genetics. Among the most intriguing projects are those that link poverty to genetic changes in children and those that strongly imply that genetic changes caused by environmental factors, as well as those that result from random mutations, can be passed from one generation to the next.
This research can be interpreted from a social justice perspective as proof that poverty, particularly child poverty, is a human rights issue. It can be used to develop interventions to help kids compensate for the effects poverty may have on their brains and bodies. It can lead to legislation that lessens the gap between the wealthy and the poor and raises everyone to an acceptable standard of living.
Or not.
As a nation that was founded and built on the premise that some people (those of Northern European extraction) are inherently and irrevocably superior to other people (pretty much everyone else), we need to be very careful about how we understand and...
Related Articles
It’s been a busy couple of months in biopolitics, with developments in the US, UK, China, Japan, and implicitly on Mars. Time for a brief roundup.
• • •
Bioethics needs an update
The National Research Act is now 50 years old. It was signed into law on July 12, 1974, as a direct response to publicity about the 1932 “Tuskegee Study of Untreated Syphilis in the Negro Male.” The Hastings Bioethics Forum celebrated its anniversary with an...
By Robert Resta, The DNA Exchange | 07.22.2024
Medical geneticists and genetic counselors have an often complicated and at times tense relationship with people with disabilities, their families, advocates, and scholars. Geneticists are strong advocates and supporters for all of their patients, regardless of their abilities and disabilities...
By Katherine Bourzac, Nature | 07.10.2024
Image courtesy National Human Genome Research Institute
The U.S. Food and Drug Administration (FDA) is supposed to encourage effective medical advances while also ensuring that patients and research subjects are protected. This dual mandate demands tricky judgment calls that are made more difficult by outside pressures of several kinds, political, judicial, and especially commercial. This April story at Bloomberg examines one deeply troubling pattern of regulatory capture:
Americans Are Paying Billions to Take Drugs That Don’t Work
Companies are increasingly...